Claro, Marvin .

HRN: 28-18-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2025
CEFTRIAXONE 1G (VIAL)
11/29/2025
12/06/2025
IV
2g
OD
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines